| Literature DB >> 32982784 |
Jenni J Hekkanen1, Tuomas V Kenttä1, Mira Anette E Haukilahti1, Janne T Rahola1, Lauri Holmström1, Juha Vähätalo1, Mikko P Tulppo1, Antti M Kiviniemi1, Lasse Pakanen2,3, Olavi H Ukkola1, M Juhani Junttila1, Heikki V Huikuri1, Juha S Perkiömäki1.
Abstract
INTRODUCTION: The prognostic significance of beat-to-beat variability of spatial heterogeneity of repolarization measured from standard 12-lead ECG is not well-understood.Entities:
Keywords: T-wave; T-wave morphology; electrocardiography; repolarization; sudden cardiac death; ventricular arrhythmias
Year: 2020 PMID: 32982784 PMCID: PMC7477294 DOI: 10.3389/fphys.2020.01045
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1(A) T-wave morphology dispersion (degrees) (TMD) is based on the T-wave loop. TMD is obtained by calculating the average angle between all possible reconstruction vector pairs of limb leads I–II and chest leads V2–V6. (B) Total cosine R-to-T reflects the spatial angle between main QRS vector and the main T-wave vector (TCRT). (C) T-window-H was defined as the height of the window encompassing T-wave loop (mV), and T-window-W was defined as the width of the window encompassing T-wave loop (mV). (D) T-wave heterogeneity (TWH) was obtained from left precordial leads (V4–V6) using second central moment analysis. It is a measure of splay of waveforms around the average waveform of T-wave.
Clinical characteristics of study subjects.
| Variable | Patients with CAD ( | Victims of SCD ( | |
| Age, years | 65 ± 10 | 64 ± 11 | 0.36 |
| Sex, male | 70.5% | 70.5% | 1.00 |
| Diabetes | 44% | 22.5% | <0.001 |
| Hypertension | 64% | 36% | <0.001 |
| LBBB | 0% | 0% | 1.00 |
| RBBB | 0% | 1.5% | 0.08 |
| RR, ms | 1026 ± 168 | 853 ± 181 | <0.001 |
| RR-SD, ms | 21.4 ± 27.4 | 18.3 ± 26.7 | 0.25 |
| β-Blocker | 89% | 20.5% | <0.001 |
| Statin | 92% | 11% | <0.001 |
| Aspirin | 97% | 14% | <0.001 |
| Diuretics | 29.5% | 16% | 0.09 |
| ACEI/ARB | 67.5% | 15% | <0.001 |
| Ca-blocker | 24.5% | 5.5% | <0.001 |
Repolarization parameters and their temporal variability.
| Variable | Patients with CAD ( | Victims of SCD ( | |
| QTc, ms | 397 ± 26 | 416 ± 38 | 5.0E-9 (0.00000008) |
| QT-SD, ms | 3.8 ± 7.1 | 8.3 ± 13.1 | 0.00003 (0.00048) |
| T-window-H, mV | 0.095 ± 0.053 | 0.107 ± 0.061 | 0.027 (0.43) |
| T-window-H-SD, mV | 0.0068 ± 0.0046 | 0.0094 ± 0.0057 | 5.9E-7 (0.0000094) |
| T-window-W, mV | 0.32 ± 0.14 | 0.33 ± 0.16 | 0.68 |
| T-window-W-SD, mV | 0.012 ± 0.007 | 0.014 ± 0.014 | 0.24 |
| TCRT | 0.21 ± 0.54 | 0.10 ± 0.53 | 0.04 (0.64) |
| TCRT-SD | 0.058 ± 0.053 | 0.088 ± 0.126 | 0.002 (0.032) |
| TMD, degrees | 33.2 ± 24.8 | 33.8 ± 25.5 | 0.79 |
| TMD-SD, degrees | 2.41 ± 2.30 | 3.24 ± 3.79 | 0.009 (0.14) |
| TMDpre, degrees | 35.0 ± 24.8 | 36.0 ± 26.2 | 0.69 |
| TMDpre-SD, degrees | 2.79 ± 2.58 | 4.66 ± 5.20 | 0.000007 (0.000112) |
| TMDpost, degrees | 26.0 ± 31.2 | 25.9 ± 29.0 | 0.96 |
| TMDpost-SD, degrees | 2.58 ± 3.80 | 3.84 ± 5.94 | 0.012 (0.19) |
| TWH, μV | 58.7 ± 40.4 | 83.0 ± 57.1 | 0.000001 (0.000016) |
| TWH-SD, μV | 3.8 ± 2.6 | 6.9 ± 5.6 | 1.8E-11 (0.000000000288) |
Association of repolarization parameters with risk of sudden cardiac death in multivariate analysis.
| Variable | Relative risk | 95% CI | |
| QTc, ms | 1.004 | 0.994–1.015 | 0.43 |
| QT-SD, ms | 1.047 | 1.013–1.082 | 0.006 |
| T-window-H, mV × 10–2 | 1.043 | 0.988–1.10 | 0.13 |
| T-window-H-SD, mV × 10–3 | 1.05 | 0.983–1.121 | 0.14 |
| TCRT × 10–1 | 1.00 | 0.947–1.057 | 0.99 |
| TCRT-SD × 10–2 | 1.044 | 1.003–1.085 | 0.03 |
| TMD-SD, degrees | 1.036 | 0.941–1.139 | 0.47 |
| TMDpre-SD, degrees | 1.057 | 0.968–1.153 | 0.22 |
| TMDpost-SD, degrees | 1.05 | 0.992–1.112 | 0.09 |
| TWH, μV | 1.014 | 1.007–1.021 | 0.0002 |
| TWH-SD, μV | 1.255 | 1.127–1.398 | 0.00003 |
Association of repolarization parameters with risk of sudden cardiac death in cox multivariate regression analysis.
| Variable | HR | 95% CI | ||
| QTc, ms | uv | 1.012 | 1.008–1.016 | 3.1E-9 |
| mv | 1.002 | 0.997–1.007 | 0.46 | |
| QT-SD, ms | uv | 1.021 | 1.012–1.031 | 0.000013 |
| mv | 1.016 | 1.002–1.031 | 0.024 | |
| T-window-H, mV × 10–2 | uv | 1.024 | 1.001–1.047 | 0.043 |
| mv | 1.021 | 0.994–1.047 | 0.12 | |
| T-window-H-SD, mV × 10–3 | uv | 1.053 | 1.032–1.075 | 5.9E-7 |
| mv | 1.016 | 0.990–1.042 | 0.24 | |
| TCRT × 10–1 | uv | 0.972 | 0.948–0.997 | 0.028 |
| mv | 0.987 | 0.960–1.016 | 0.38 | |
| TCRT-SD × 10–2 | uv | 1.019 | 1.008–1.031 | 0.001 |
| mv | 1.012 | 1.000–1.025 | 0.047 | |
| TMD-SD, degrees | uv | 1.054 | 1.018–1.092 | 0.003 |
| mv | 1.028 | 0.981–1.078 | 0.25 | |
| TMDpre-SD, degrees | uv | 1.061 | 1.036–1.087 | 0.000001 |
| mv | 1.029 | 0.995–1.064 | 0.096 | |
| TMDpost-SD, degrees | uv | 1.035 | 1.011–1.059 | 0.004 |
| mv | 1.026 | 1.000–1.052 | 0.054 | |
| TWH, μV | uv | 1.005 | 1.003–1.007 | 0.000007 |
| mv | 1.002 | 1.000–1.005 | 0.062 | |
| TWH-SD, μV | uv | 1.070 | 1.051–1.090 | 5.3E-13 |
| mv | 1.054 | 1.020–1.090 | 0.002 |
FIGURE 2Receiver operating characteristic curves for TWH-SD (A), QT-SD (B), and TWH (C) in discriminating the victims of SCD from the patients with CAD. AUC, area under the curve. Other abbreviations are the same as in Table 2.
Association of beta blocker medication with TWH-SD, TWH, and QT-SD.
| (A) In patients with CAD | |||
| Variable | No beta blocker medication | Beta blocker medication | |
| TWH-SD | 3.9 ± 2.8, μV | 3.8 ± 2.6, μV | 0.88 |
| TWH | 60.4 ± 37.5, μV | 58.5 ± 40.9, μV | 0.83 |
| QT-SD | 2.9 ± 2.9, ms | 3.9 ± 7.4, ms | 0.51 |
| TWH-SD | 6.6 ± 4.0, μV | 6.3 ± 5.9, μV | 0.79 |
| TWH | 84.4 ± 59.3, μV | 78.3 ± 54.5, μV | 0.57 |
| QT-SD | 7.1 ± 10.2, ms | 8.5 ± 13.0, ms | 0.50 |
Association of RR Interval with TWH-SD, TWH, and QT-SD.
| (A) In patients with CAD | |
| TWH-SD | 0.11 (0.12) |
| TWH | 0.21 (0.002) |
| QT-SD | −0.01 (0.88) |
| TWH-SD | −0.13 (0.08) |
| TWH | 0.12 (0.10) |
| QT-SD | −0.12 (0.08) |